VISTOGARD is a Oral Granule in the Human Prescription Drug category. It is labeled and distributed by Wellstat Therapeutics Corporation. The primary component is Uridine Triacetate.
| Product ID | 69468-151_8e64b577-1ecb-46f2-a7c8-3577a16f8837 |
| NDC | 69468-151 |
| Product Type | Human Prescription Drug |
| Proprietary Name | VISTOGARD |
| Generic Name | Uridine Triacetate |
| Dosage Form | Granule |
| Route of Administration | ORAL |
| Marketing Start Date | 2016-03-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA208159 |
| Labeler Name | Wellstat Therapeutics Corporation |
| Substance Name | URIDINE TRIACETATE |
| Active Ingredient Strength | 951 mg/g |
| Pharm Classes | Pyrimidine Analog [EPC],Pyrimidines [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2016-03-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA208159 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-03-01 |
| Marketing Category | NDA |
| Application Number | NDA208159 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-03-01 |
| Marketing Category | NDA |
| Application Number | NDA208159 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-03-01 |
| Ingredient | Strength |
|---|---|
| URIDINE TRIACETATE | 951 mg/g |
| SPL SET ID: | 5a0ba417-8a4a-4d7f-b85a-1839ee8bd3f1 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 69468-151 | VISTOGARD | uridine triacetate |
| 69468-152 | XURIDEN | uridine triacetate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() VISTOGARD 85386983 4859937 Live/Registered |
Wellstat Therapeutics Corporation 2011-08-02 |